Bayer's Silver Bullet

Just two months ago, shares in the German chemical giant Bayer fell sharply after the company withdrew a cholesterol-lowering drug from the market in the wake of 52 related deaths. Now those shares have partly bounced back because of another tragedy: Bayer’s antibiotic Cipro is the drug of choice for treating anthrax, the deadly illness that has infected one person in Kenya, several in the U.S. — and terrorized millions around the world.

Talk about a silver lining. As worried Americans rushed out to buy Cipro — 14,800 prescriptions were filled in New York City in just one...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!